R
Ralph B. D'Agostino
Researcher at Wake Forest University
Publications - 1336
Citations - 250792
Ralph B. D'Agostino is an academic researcher from Wake Forest University. The author has contributed to research in topics: Framingham Heart Study & Framingham Risk Score. The author has an hindex of 226, co-authored 1287 publications receiving 229636 citations. Previous affiliations of Ralph B. D'Agostino include VA Boston Healthcare System & University of Illinois at Urbana–Champaign.
Papers
More filters
Journal ArticleDOI
Inclusion of Stroke in Cardiovascular Risk Prediction Instruments A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Daniel T. Lackland,Mitchell S.V. Elkind,Ralph B. D'Agostino,Mandip S. Dhamoon,David C. Goff,Randall T. Higashida,Leslie A. McClure,Pamela H. Mitchell,Ralph L. Sacco,Cathy A. Sila,Sidney C. Smith,David Tanne,David L. Tirschwell,Emmanuel Touzé,Lawrence R. Wechsler +14 more
TL;DR: This statement provides an overview of evidence and arguments supporting the inclusion of patients with stroke, and atherosclerotic stroke in particular, among those considered to be at high absolute risk of cardiovascular disease and theclusion of stroke as part of the outcome cluster in risk prediction instruments for vascular disease.
Journal ArticleDOI
Vitamin K and Vitamin D Status: Associations with Inflammatory Markers in the Framingham Offspring Study
M. Kyla Shea,Sarah L. Booth,Joseph M. Massaro,Paul F. Jacques,Ralph B. D'Agostino,Bess Dawson-Hughes,Jose M. Ordovas,Christopher J. O'Donnell,Sekar Kathiresan,John F. Keaney,Ramachandran S. Vasan,Ramachandran S. Vasan,Emelia J. Benjamin +12 more
TL;DR: The observation that high vitamin K status was associated with lower concentrations of inflammatory markers suggests that a possible protective role for vitamin K in inflammation merits further investigation.
Journal ArticleDOI
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Peter W.F. Wilson,Michael J. Pencina,Paul F. Jacques,Jacob Selhub,Ralph B. D'Agostino,Christopher J. O'Donnell +5 more
TL;DR: Circulating levels of CRP help to estimate risk for initial cardiovascular events and may be used most effectively in persons at intermediate risk for vascular events, offering moderate improvement in reclassification of risk.
Journal ArticleDOI
Phase II Study of Donepezil in Irradiated Brain Tumor Patients: Effect on Cognitive Function, Mood, and Quality of Life
Edward G. Shaw,Robin Rosdhal,Ralph B. D'Agostino,James Lovato,Michelle J. Naughton,Michael E. Robbins,Stephen R. Rapp +6 more
TL;DR: Cognitive functioning, mood, and health-related QOL were significantly improved following a 24-week course of the acetylcholinesterase inhibitor donepezil in irradiated brain tumor patients.
Journal ArticleDOI
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
Arend Mosterd,Ralph B. D'Agostino,Halit Silbershatz,Pamela A. Sytkowski,William B. Kannel,Diederick E. Grobbee,Daniel Levy +6 more
TL;DR: The notion that the increasing use of antihypertensive medication has resulted in a reduced prevalence of high blood pressure and a concomitant decline in left ventricular hypertrophy in the general population is supported.